SCHEMBL2840254

SCHEMBL2840254

Cc1cccc(C(=O)Nc2ccc(C(C(=O)NO)c3ccccc3)cc2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNK3 O14649 6/20 0.59
KCNK9 Q9NPC2 6/20 0.59
MEN1 O00255 5/20 0.59
KMT2A Q03164 5/20 0.59
NPC1 O15118 5/20 0.59
RAB9A P51151 4/20 0.59
TP53 P04637 2/20 0.59
POLB P06746 1/20 0.59
FFAR1 O14842 1/20 0.56
GLA P06280 1/20 0.56
KCNH2 Q12809 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.55
NT5E P21589 1/20 0.54
HDAC8 Q9BY41 3/20 0.53
HDAC6 Q9UBN7 3/20 0.53
HDAC1 Q13547 2/20 0.53
HDAC2 Q92769 2/20 0.53
HDAC3 O15379 1/20 0.53
HDAC4 P56524 1/20 0.53
HDAC7 Q8WUI4 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20490320 0.91 KCNK3 (0.65) KCNK3KCNK9MEN1KMT2ANPC1
SCHEMBL2839655 0.87 HDAC2 (0.66) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL2848079 0.86 NPC1 (0.63) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL8117004 0.85 HDAC2 (0.62) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL2841101 0.85 RAB9A (0.64) KCNK3MEN1KMT2ANPC1RAB9A
SCHEMBL2839158 0.85 MEN1 (0.60) KCNK3KCNK9MEN1KMT2ANPC1
SCHEMBL2837576 0.85 NPC1 (0.59) MEN1KMT2ANPC1RAB9ATP53
SCHEMBL20490136 0.84 NPC1 (0.68) KCNK3KCNK9MEN1KMT2ANPC1
SCHEMBL2839081 0.82 POLB (0.49) MEN1KMT2ANPC1RAB9APOLB
SCHEMBL2839094 0.82 HDAC1 (0.53) MEN1KMT2ANPC1RAB9ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139850-B1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC (CA) 2018-09-12 EP claimed
CN-101679220-A Histone deacetylase inhibitor METHYLGENE INC 2010-03-24 CN claimed
EP-2139850-A1 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2010-01-06 EP claimed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US claimed
WO-2008122115-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2008-10-16 WO claimed
EP-2139850-B1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC (CA) 2018-09-12 EP disclosed
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
CN-101679220-A Histone deacetylase inhibitor METHYLGENE INC 2010-03-24 CN disclosed
EP-2139850-A1 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2010-01-06 EP disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed
WO-2008122115-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2008-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181943-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC11, HDAC3 KCNK3 2782/4885KCNK9 1631/4885MEN1 1925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.